BURNABY, BC, Jan. 25 /CNW/ - Welichem Biotech Inc. (the "Company")
(TSX-V: WBI), announced today that Mr. Weihe Wang and Mr. Zhaofang Zhang
resigned as directors of the Company and that Mr. Wenfeng Liu and Ms. Mingrong
Lu joined the Company as directors, effective January 24, 2008. The Company
would like to thank Mr. Wang and Mr. Zhang for their valued contribution to
Mr. Liu is a very successful entrepreneur and is Chairman of the Board
and a founding shareholder of Hebei Wenfeng Iron and Steel Co. Ltd. He has
held senior management and executive positions in various companies in China.
Mr. Liu is a principal of Canadian Maple Leaf Investment Ltd. (CMLI) that is
one of the major shareholders of the Company.
Ms. Lu is a very successful entrepreneur and a founding shareholder of
Hebei Wenfeng Iron and Steel Co. Ltd. She has held management and executive
positions in several companies in China. Ms. Lu is also a principal of
Canadian Maple Leaf Investment Ltd. (CMLI).
Dr. Hugh Wynne-Edwards, Chairman, stated "We are very pleased to have Mr.
Liu and Ms. Lu as members of our Board at this exciting stage of development
of the Company. They bring to the Company a wealth of experience in business
development and in raising capital, which is valuable for the success of our
About Welichem Biotech Inc.
Welichem Biotech Inc. is a publicly-traded biotechnology company
developing therapeutic drugs in the fields of autoimmune diseases and cancer.
ON BEHALF OF THE BOARD
York Yingping Guo
President & Chief Executive Officer
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the content of this news
release. This press release contains forward-looking statements that include
our belief as to the potential of our products. Certain risks and
uncertainties such as our ability to successfully commercialize the products
could cause the Company's actual results to differ materially from those in
the forward-looking statements.
For further information:
For further information: York Yingping Guo, Tel.: (604) 432-1703, Email: